Zinzani, P. L., Dreyling, M., Gradishar, W., Andre, M., Esteva, F. J., Boulos, S., . . . Curigliano, G. (2019). Are Biosimilars the Future of Oncology and Haematology? Drugs, 79(15), 1609. https://doi.org/10.1007/s40265-019-01193-y
Chicago Style (17th ed.) CitationZinzani, Pier Luigi, Martin Dreyling, William Gradishar, Marc Andre, Francisco J. Esteva, Suliman Boulos, Eva González Barca, and Giuseppe Curigliano. "Are Biosimilars the Future of Oncology and Haematology?" Drugs 79, no. 15 (2019): 1609. https://doi.org/10.1007/s40265-019-01193-y.
MLA (9th ed.) CitationZinzani, Pier Luigi, et al. "Are Biosimilars the Future of Oncology and Haematology?" Drugs, vol. 79, no. 15, 2019, p. 1609, https://doi.org/10.1007/s40265-019-01193-y.
Warning: These citations may not always be 100% accurate.